SERUM AMYLOID A PROTEIN (SAA) - ANVISA Registration 81086830069

Access comprehensive regulatory information for SERUM AMYLOID A PROTEIN (SAA) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81086830069 and manufactured by BEIJING DIAGREAT BIOTECHNOLOGIES CO., LTD.. The registration is held by FASTTEST DISTRIBUIDORA DE PRODUTOS PARA LABORATÓRIOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ZYBIO INC., SHENZHEN LIFOTRONIC TECHNOLOGY CO., LTD., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
81086830069
Registration Details
ANVISA Registration Number: 81086830069
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Serum Amyloid A Determination Kit
Risk Class II

Registration Details

81086830069

25351287684202390

20037992000139

Company Information

China
PT: CHINA, REPÚBLICA POPULAR

Dates and Status

May 29, 2023

VIGENTE

09/18/2025 19:00:01